REQUEST A DEMO
Total
USD $0.00
Search more companies

Genomictree, Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Genomictree, Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the genomic analysis. The Company is involved in conducting of genomic analysis using microarrays and next generation sequencing analysis. In addition, the Company is conducting clinical trials for molecular diagnostic products. Molecular diagnostic products include cancer molecular diagnostic products and molecular genetic diagnostic products. Cancer molecular diagnostic products include molecular diagnostic products for colorectal cancer, bladder cancer, lung cancer, stomach cancer, cervical cancer. Molecular genetic diagnostic products include epidermal growth factor receptor (EGFR) mutation diagnosis, as well as human papilloma virus (HPV) diagnostic products. The Company was established on October 06, 2000. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on March 27, 2019.

Headquarters
44-6, Techno 10-Ro, Yuseong-Gu, Daejeon
Daejeon; Daejeon;

Contact Details: Purchase the Genomictree, Inc. report to view the information.

Website: http://genomictree.com/ko

Basic Information
Total Employees:
Purchase the Genomictree, Inc. report to view the information.
Outstanding Shares:
Purchase the Genomictree, Inc. report to view the information.
Registered Capital:
Purchase the Genomictree, Inc. report to view the information.
Financial Auditors:
Purchase the Genomictree, Inc. report to view the information.
Incorporation Date:
October 15, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
17.7%
Purchase this report to view the information.
8.4%
Purchase this report to view the information.
6.3%
Subsidiaries
Promis Diagnostics Inc
Company Performance
Financial values in the chart are available after Genomictree, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-88.56%
Total operating revenue
-74.58%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-44.4%
Total assets
-18.46%
Total equity
16.25%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-242.63%
Return on Equity (ROE)
-1.4%
Debt to Equity Ratio
-25.66%
Quick Ratio
15.77%
Cash Ratio
7.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?